Lisdexamfetamine, marketed as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in kids and individuals. In Canada, its access is overseen by Health Canada. This https://sandozlisdexamfetaminein586040.ja-blog.com/43135828/vyvanse-in-canada-a-comprehensive-guide